Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Roulia P, Mantalovas S, Dagher M, Karakousis AV, Varsamis N, Vlassopoulos K, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C.
Katopodi T, et al. Among authors: grigoriadou e.
Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455.
Pharmaceutics. 2024.
PMID: 38675116
Free PMC article.
Review.